TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
EMM Life Science AB
Closing information (x1000 SEK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
36,341
|
32,319
|
27,283 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
10,024
|
9,554
|
4,343 |
| EBITDA |
10,165
|
9,468
|
2,173 |
| Total assets |
16,500
|
13,621
|
6,592 |
| Current assets |
15,503
|
13,559
|
6,503 |
| Current liabilities |
5,859
|
5,930
|
2,815 |
| Equity capital |
10,641
|
7,690
|
3,773 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
4
|
4
|
2 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
64.5%
|
56.5%
|
57.2% |
| Turnover per employee |
9,085
|
8,080
|
13,642 |
| Profit as a percentage of turnover |
27.6%
|
29.6%
|
15.9% |
| Return on assets (ROA) |
60.8%
|
70.1%
|
65.9% |
| Current ratio |
264.6%
|
228.7%
|
231.0% |
| Return on equity (ROE) |
94.2%
|
124.2%
|
115.1% |
| Change turnover |
4,022
|
5,036
|
-437 |
| Change turnover % |
12%
|
18%
|
-2% |
| Chg. No. of employees |
0
|
2
|
0 |
| Chg. No. of employees % |
0%
|
100%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.